Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Non-cash Items (2024 - 2025)

BioAge Labs (BIOA) has disclosed Non-cash Items for 2 consecutive years, with $46.2 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 4425.05% to $46.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.2 million through Dec 2025, up 4425.05% year-over-year, with the annual reading at $46.2 million for FY2025, 4425.05% up from the prior year.
  • Non-cash Items hit $46.2 million in Q4 2025 for BioAge Labs, up from $5.5 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $59.5 million in Q3 2024 to a low of $155000.0 in Q1 2025.